Insulet PODD
NASDAQ PODD
$148.16 +1.29 (+0.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Insulet (PODD) Cash & Current Investments (2010 - 2026)

Insulet's (PODD) quarterly Cash & Current Investments came in at $480.4 million in Q1 2026, down 62.56% YoY from $1.3 billion in Q1 2025, and down 32.91% on a QoQ basis from $716.1 million in Q4 2025.

Insulet (PODD) Cash & Current Investments (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Cash & Current Investments data on file, last reported at $480.4 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 62.56% year-over-year to $480.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.4 million (down 62.56% YoY) and the FY2025 annual result came in at $716.1 million, down 24.89% from the prior year.
  • Cash & Current Investments declined to $480.4 million in Q1 2026, from $716.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.3 billion in Q1 2025 to a low of $480.4 million in Q1 2026.
  • A 5-year average of $782.7 million and a median of $716.1 million in 2025 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2025 — Cash & Current Investments surged 70.81% — and 2026, when it sank 62.56%.
  • Tracing PODD's Cash & Current Investments over 5 years: stood at $675.2 million in 2022, then rose by 4.3% to $704.2 million in 2023, then jumped by 35.39% to $953.4 million in 2024, then slipped by 24.89% to $716.1 million in 2025, then tumbled by 32.91% to $480.4 million in 2026.
  • The last three Cash & Current Investments figures came in at $480.4 million (Q1 2026), $716.1 million (Q4 2025), and $757.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 5.60 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 3.48 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 539.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 4.25 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 1.95 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 2.11 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 3.32 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 482.30 Mn
10 Insulet 10.27 Bn 9.74 Bn 562.60 Mn 534.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 534.90 Mn
Mar 31, 2026 480.40 Mn
Dec 31, 2025 716.10 Mn
Sep 30, 2025 757.40 Mn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 953.40 Mn
Sep 30, 2024 902.60 Mn
Jun 30, 2024 821.00 Mn
Mar 31, 2024 751.20 Mn
Dec 31, 2023 704.20 Mn
Sep 30, 2023 701.00 Mn
Jun 30, 2023 675.50 Mn
Mar 31, 2023 620.70 Mn
Dec 31, 2022 675.20 Mn
Sep 30, 2022 722.50 Mn
Jun 30, 2022 709.80 Mn
Mar 31, 2022 710.70 Mn
Dec 31, 2021 793.20 Mn
Sep 30, 2021 857.10 Mn